Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De-escalation”

259 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 259 results

Not applicableUnknownNCT04012502
What this trial is testing

De-escalation Protocols in HPV-related Oropharyngeal Carcinoma in Chinese Populations

Who this might be right for
Oropharyngeal CarcinomaDe-escalation
Fudan University 83
Post-approval studies (Phase 4)Study completedNCT04982172
What this trial is testing

Model-informed Dose De-escalation of Infliximab in Patients With Inflammatory Bowel Diseases

Who this might be right for
Inflammatory Bowel Diseases
Universitaire Ziekenhuizen KU Leuven 80
Testing effectiveness (Phase 2)Study completedNCT01839916
What this trial is testing

Donor T Cells After Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Del(5q)+61 more
University of Chicago 77
Not applicableStudy completedNCT05419687
What this trial is testing

Violence Against Health Care Workers in Fragile Settings

Who this might be right for
Workplace Violence
Swiss Tropical & Public Health Institute 798
Not applicableStudy completedNCT03248258
What this trial is testing

Enhancing Shared Decision-Making in Metastatic Breast Cancer (Qualitative Study)

Who this might be right for
Decision Making ,SharedDe-escalation
University of Alabama at Birmingham 200
Not applicableNot Yet RecruitingNCT07098507
What this trial is testing

De-escalation in Axillary Surgery for Early-stage Breast Cancer

Who this might be right for
Omitting Sentinel Lymph Node Biopsy in Early-stage Breast Cancer
Clinical Hospital Center Rijeka 620
Not applicableEnded earlyNCT01891695
What this trial is testing

OPSCC N0 Nodal Control With Reduced IMRT

Who this might be right for
Oropharyngeal Squamous Cell Carcinoma (OPSCCA)HPV (Human Papillomavirus)-Associated
Paul W. Read, MD 1
Not applicableUnknownNCT05914402
What this trial is testing

Axillary Surgery De-escalation After Neoadjuvant Therapy Using Dedicate Breast PET

Who this might be right for
Breast Cancer
Fudan University 100
Not applicableLooking for participantsNCT07466238
What this trial is testing

HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer

Who this might be right for
Biliary Tract Cancer (BTC)
Peking University 40
Early research (Phase 1)WithdrawnNCT05773664
What this trial is testing

Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma

Who this might be right for
GlioblastomaMalignant Glioma
City of Hope Medical Center
Large-scale testing (Phase 3)UnknownNCT05903976
What this trial is testing

De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS

Who this might be right for
Dual Antiplatelet TherapyAcute Coronary SyndromeCoronary Artery Disease
Azienda Ospedaliera Universitaria Policlinico "G. Martino" 200
Testing effectiveness (Phase 2)Looking for participantsNCT07209189
What this trial is testing

Neoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatment De-escalation (NeoScorch HN)

Who this might be right for
Head and Neck CancerSquamous Cell CarcinomaOral Cavity Cancer+6 more
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 75
Early research (Phase 1)Ended earlyNCT04271306
What this trial is testing

Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania.

Who this might be right for
Malaria,Falciparum
University of Oxford 34
Testing effectiveness (Phase 2)Looking for participantsNCT06702033
What this trial is testing

The Minimalist Trial-2

Who this might be right for
HPV-Related Oropharynx Squamous Cell Carcinoma
Washington University School of Medicine 142
Large-scale testing (Phase 3)Ended earlyNCT05479058
What this trial is testing

A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission

Who this might be right for
Ulcerative Colitis
Galapagos NV 22
Early research (Phase 1)Study completedNCT01856634
What this trial is testing

Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis

Who this might be right for
Multidrug Resistant TuberculosisPediatric
Otsuka Pharmaceutical Development & Commercialization, Inc. 37
Large-scale testing (Phase 3)Study completedNCT05955612
What this trial is testing

Use of Procalcitonin, a Blood Test to Guide Antibiotic Therapy for Sepsis in Adults

Who this might be right for
Sepsis
University of Oxford 532
Early research (Phase 1)Study completedNCT03064763
What this trial is testing

Study to Evaluate the Safety/ Efficacy of T-VEC in Japanese Subjects With Unresectable Stage IIIB-IV Malignant Melanoma

Who this might be right for
Unresectable Stage IIIB-IV Malignant Melanoma
Amgen 18
Early research (Phase 1)WithdrawnNCT04602117
What this trial is testing

ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer

Who this might be right for
HER2-positive Breast CancerHER2 LowSYD-985+24 more
QuantumLeap Healthcare Collaborative
Testing effectiveness (Phase 2)Looking for participantsNCT04444869
What this trial is testing

Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal Cancer

Who this might be right for
Cancer of the Head and NeckOropharynx CancerHPV Positive Oropharyngeal Squamous Cell Carcinoma+1 more
University of Missouri-Columbia 28
Load More Results